Moderna, Inc. Quarterly Operating Income (Loss) in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Moderna, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2017 to Q2 2024.
  • Moderna, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.36B, a 27% increase year-over-year.
  • Moderna, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$4.64B, a 1004% decline year-over-year.
  • Moderna, Inc. annual Operating Income (Loss) for 2023 was -$4.24B, a 145% decline from 2022.
  • Moderna, Inc. annual Operating Income (Loss) for 2022 was $9.42B, a 29.2% decline from 2021.
  • Moderna, Inc. annual Operating Income (Loss) for 2021 was $13.3B.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$4.64B -$1.36B +$504M +27% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$5.14B -$1.27B -$900M -246% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$4.24B $6M -$1.57B -99.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$2.67B -$2.01B -$3.18B -273% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $513M -$1.87B -$4.31B -176% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $4.83B -$366M -$4.59B -109% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $9.42B $1.58B -$3.83B -70.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $13.3B $1.17B -$2.39B -67.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $15.6B $2.45B -$615M -20.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $16.3B $4.23B +$2.96B +234% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $13.3B $5.41B +$5.69B Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $7.61B $3.56B +$3.79B Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.82B $3.06B +$3.18B Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $634M $1.27B +$1.4B Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$763M -$275M -$144M -111% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$619M -$235M -$104M -79.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$514M -$122M +$21.7M +15.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$536M -$131M +$10.6M +7.51% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$547M -$131M +$22.5M +14.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-02-27
Q3 2019 -$569M -$131M -$44.9M -52.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$524M -$144M -$46.7M -48.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$478M -$142M -$64.2M -83% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$413M -$153M -$111M -266% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$302M -$85.8M -$17.9M -26.4% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$284M -$97M -$2.82M -3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$281M -$77.4M -$11.9M -18.2% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$269M -$41.8M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$67.9M Jul 1, 2017 Sep 30, 2017 10-K 2019-03-13
Q2 2017 -$94.2M Apr 1, 2017 Jun 30, 2017 10-K 2019-03-13
Q1 2017 -$65.5M Jan 1, 2017 Mar 31, 2017 10-K 2019-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.